Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity

Detalles Bibliográficos
Autores principales: Wang, Zhenzhen, Lu, Yang, Liu, Yu, Mou, Junli, Liu, Xiaoyu, Chen, Manling, Wang, Ying, Xu, Yingxi, Rao, Qing, Xing, Haiyan, Tang, Kejing, Tian, Zheng, Wang, Bing, Qi, Wei, Wang, Min, Qiu, Shaowei, Xiong, Dongsheng, Wang, Jianxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565379/
https://www.ncbi.nlm.nih.gov/pubmed/37525513
http://dx.doi.org/10.1002/cac2.12474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565379/
https://www.ncbi.nlm.nih.gov/pubmed/37525513
http://dx.doi.org/10.1002/cac2.12474

Ejemplares similares